From: Egyptian practical guidance in hypertriglyceridemia management 2021
Drug | Lipid effects |
---|---|
Fenofibrate | LDL ↓: 20.6% (145 mg) HDL ↑: 11% (145 mg) TG ↓: 23.5–50.6% (greatest drop is in patients with highest TG) (145 mg) |
IPE | HDL ↑: 9.1% (4 g/day) TG ↓: 45% (4 g/day) |
Niacin | LDL ↓: 14–17% (2 g/day) HDL ↑: 22–26% (2 g/day) TG ↓: 20–50% |
Ezetimibe | LDL ↓: 18% (10 mg/day) HDL ↑: 1% (10 mg/day) TG ↓: 8% |
Statins | LDL ↓: 30–50% (dose, and drug dependent) HDL ↑: 1–10% TG ↓: 10–30% |